Two Sigma Investments, LP Bionomics Limited Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.69 - $1.2 $482 - $840
-700 Reduced 4.1%
16,370 $12,000
Q1 2024

May 15, 2024
SELL
$0.89 - $1.38 $12,639 - $19,598
-14,202 Reduced 45.41%
17,070 $17,000
Q4 2023

Feb 14, 2024
BUY
$1.13 - $4.46 $35,337 - $139,473
31,272 New
31,272 $46,000

Others Institutions Holding BNOX

# of Institutions
10
Shares Held
2.5M
Call Options Held
0
Put Options Held
0
View Full List

About BIONOMICS LIMITED

BNOX Quotes by TradingView
  • Ticker BNOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,518,620
  • Market Cap $33.5M
  • Description
  • Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...
More about BNOX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email